data_3eze_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3eze _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H1 ' ' H ' ' A' ' 2' ' ' ILE . 55.7 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.161 -0.681 . . . . 3.94 109.161 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 86.8 mt -95.65 122.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 1.62 108.95 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -130.04 139.79 50.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.564 -0.71 . . . . 1.18 109.931 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.44 -164.07 12.18 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.442 -1.863 . . . . 0.7 108.442 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.7 mt -90.22 -13.17 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.703 -1.469 . . . . 1.35 110.546 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.2 tp 52.45 102.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.071 -1.018 . . . . 1.28 109.245 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.87 -31.02 13.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 1.38 109.352 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 6.0 m -131.26 122.68 19.22 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.686 . . . . 1.93 109.152 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.83 145.78 16.1 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.755 1.637 . . . . 0.65 112.195 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.38 -160.3 31.22 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 108.978 -1.649 . . . . 0.61 108.978 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -147.62 150.08 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 120.871 -1.37 . . . . 1.19 108.049 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.73 154.04 32.22 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.576 -1.328 . . . . 1.12 110.617 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.1 m-85 -133.19 127.24 33.36 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.172 -1.047 . . . . 0.62 108.172 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.73 179.93 48.06 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.548 -1.787 . . . . 0.39 111.072 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -80.09 158.39 26.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.698 -0.883 . . . . 2.21 109.4 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.48 127.06 52.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.5 -0.75 . . . . 1.14 110.986 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.76 138.15 36.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.953 -1.499 . . . . 1.15 106.953 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -119.44 124.36 46.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.353 -0.842 . . . . 1.26 109.259 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.06 104.39 15.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 1.34 110.427 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -98.73 128.91 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.481 -0.762 . . . . 2.34 109.263 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -131.11 132.89 45.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.291 -0.881 . . . . 2.32 109.503 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -74.84 147.29 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.81 -1.182 . . . . 2.08 109.145 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.14 142.03 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 1.93 109.272 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.93 130.0 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -0.807 . . . . 1.2 109.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.25 128.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.285 -0.884 . . . . 1.23 109.507 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.84 137.31 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.489 -0.757 . . . . 1.17 109.045 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.32 119.47 32.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 1.24 109.435 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -89.99 0.09 57.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.613 -0.884 . . . . 3.53 108.613 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.43 139.95 58.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 2.37 109.166 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -84.24 150.14 25.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.735 -1.228 . . . . 2.87 109.753 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.04 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.492 -0.755 . . . . 1.17 109.84 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -96.9 174.33 6.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 1.12 108.529 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.06 79.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 1.29 109.442 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -55.11 -30.27 59.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.546 -1.346 . . . . 2.34 109.32 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.65 -9.95 59.16 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.21 -0.931 . . . . 1.61 110.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -64.07 -53.36 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.706 -1.247 . . . . 1.15 108.266 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.76 -40.19 91.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.184 -0.948 . . . . 1.24 110.119 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -68.8 -40.3 79.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 2.72 110.93 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -65.18 -40.24 93.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.795 -1.191 . . . . 1.23 109.81 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.98 -45.96 94.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.991 -1.114 . . . . 1.19 107.991 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.36 -40.8 92.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.12 . . . . 1.35 109.48 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -60.04 -43.44 95.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.65 -1.22 . . . . 3.35 107.761 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.54 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.626 -0.879 . . . . 0.82 108.626 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -60.17 -47.37 86.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.503 -0.748 . . . . 1.32 109.362 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -64.99 -43.35 92.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.162 -0.961 . . . . 1.18 109.139 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.67 -45.24 96.2 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.407 -1.877 . . . . 0.49 108.407 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -65.99 -37.94 87.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -1.054 . . . . 3.22 108.824 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.1 62.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.541 -0.911 . . . . 1.25 108.541 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -64.62 -74.9 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.47 -1.308 . . . . 2.75 107.47 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.57 -36.86 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.478 -0.764 . . . . 1.19 111.463 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -55.12 -57.94 9.68 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.778 -1.201 . . . . 1.85 108.745 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.06 76.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 1.16 111.461 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.57 -40.47 88.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.625 -1.297 . . . . 1.89 110.259 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.17 -40.0 95.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 1.19 108.999 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -60.25 -37.35 80.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.17 109.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.5 m -65.07 -41.34 95.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.001 -1.062 . . . . 1.13 109.419 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -62.7 -38.96 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 1.15 108.838 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -57.95 -50.01 74.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.288 -0.883 . . . . 1.62 109.591 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -59.5 -34.05 72.12 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.379 -0.825 . . . . 1.13 109.915 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.16 -38.49 78.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 2.29 109.379 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.03 97.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.631 -0.668 . . . . 1.1 109.52 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.13 -55.83 21.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.657 -1.377 . . . . 0.43 109.657 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -59.89 -48.89 79.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.124 -1.221 . . . . 1.21 109.532 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -68.09 -58.02 5.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 1.08 111.716 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -95.94 -58.02 2.2 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.015 -1.053 . . . . 0.53 111.299 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.49 -170.01 25.27 Favored Glycine 0 N--CA 1.501 2.983 0 C-N-CA 119.781 -1.2 . . . . 0.4 111.213 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' O ' ' NH1' ' B' ' 317' ' ' ARG . 40.9 tt0 -70.32 -26.06 63.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.072 -0.663 . . . . 1.27 110.586 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -63.56 -36.06 82.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 1.33 110.64 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -101.0 -23.61 14.48 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.017 -1.052 . . . . 1.14 109.886 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -63.97 -40.18 95.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.135 -0.978 . . . . 1.18 110.44 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -63.67 -29.51 70.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 1.08 109.98 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.04 -40.81 84.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.971 -1.122 . . . . 1.16 107.971 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.74 -39.86 88.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 1.35 110.209 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.544 ' CD ' ' HZ2' ' B' ' 324' ' ' LYS . 72.0 tt0 -59.82 -40.24 87.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.001 -1.062 . . . . 1.21 109.53 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.52 -45.5 92.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.77 -1.732 . . . . 0.28 108.77 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -60.16 -43.4 95.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.71 109.2 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.13 -46.27 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.026 . . . . 1.11 109.122 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.5 ttp -60.37 -43.13 96.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 1.08 110.082 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.41 -40.1 93.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.147 -0.971 . . . . 1.07 109.309 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.11 -39.89 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.794 -0.567 . . . . 1.14 110.073 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.54 4.29 21.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.999 -1.063 . . . . 1.23 110.108 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.89 130.38 21.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.129 -0.982 . . . . 1.2 109.619 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.22 -19.49 54.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.59 -0.694 . . . . 1.32 110.897 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.16 -34.13 70.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.064 . . . . 1.24 108.869 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.9 -41.73 74.33 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.479 0.657 . . . . 1.09 109.533 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.13 -48.16 82.87 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.155 -0.966 . . . . 1.19 110.236 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.68 -40.29 76.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.7 111.52 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.91 -39.49 72.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.947 -1.095 . . . . 1.29 111.89 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -69.29 -44.77 80.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.04 -1.038 . . . . 1.09 108.784 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -68.2 -38.99 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.774 . . . . 1.14 110.519 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.27 91.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.102 . . . . 1.15 110.581 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.6 mt -60.14 -47.41 86.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.893 -1.129 . . . . 1.17 110.005 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.6 mt -61.52 -49.29 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.918 0.866 . . . . 1.16 108.998 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -68.61 -42.8 77.62 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.919 -0.712 . . . . 2.27 110.69 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -81.13 -51.9 7.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.062 -1.024 . . . . 1.27 112.17 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mttm -90.62 -1.9 57.87 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.062 -1.024 . . . . 2.36 112.417 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 57.12 37.78 28.7 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.825 -1.172 . . . . 1.98 109.47 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.0 mtp -90.7 165.82 13.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.735 -0.603 . . . . 2.05 109.714 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.6 p -79.9 161.73 25.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 1.13 108.904 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.78 -39.02 80.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 1.17 110.005 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.28 -39.14 92.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.003 -1.061 . . . . 2.14 110.034 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.44 -40.05 27.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 1.07 110.157 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.72 47.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 1.08 110.328 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -39.76 88.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.956 -1.09 . . . . 1.1 110.118 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.6 t60 -60.52 -40.55 91.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -0.991 . . . . 0.76 109.853 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -62.08 -39.85 93.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.169 -0.957 . . . . 1.24 110.274 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.74 -53.9 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 1.11 111.709 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.39 -40.04 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.826 -1.171 . . . . 1.11 108.677 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.489 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.71 -39.74 94.17 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.204 -1.036 . . . . 1.99 108.204 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.79 95.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.905 -1.278 . . . . 0.41 109.905 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -69.87 -52.22 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.791 -1.417 . . . . 1.96 109.415 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.97 -39.9 79.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 1.14 108.901 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.9 t -59.14 -39.98 84.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.242 -0.911 . . . . 1.83 108.68 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.39 90.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 1.14 109.174 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.9 mt -65.34 -40.23 93.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.971 -1.081 . . . . 1.17 109.992 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.96 -29.49 68.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.69 -1.256 . . . . 1.6 109.558 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.93 -22.34 62.32 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.606 -0.887 . . . . 1.46 108.606 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 146.13 51.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.436 -0.95 . . . . 1.18 108.436 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.22 17.09 13.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.09 -1.006 . . . . 2.26 110.461 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.2 t0 -108.27 142.89 37.88 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.217 -0.927 . . . . 1.26 109.863 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 124' ' ' LYS . 25.4 mt-10 -73.03 -60.41 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.509 -1.293 . . . . 2.58 107.509 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.503 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 5.4 t80 -37.17 -41.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.905 -0.589 . . . . 1.24 110.953 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 mt -78.6 -32.12 47.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.524 -1.36 . . . . 1.18 108.364 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 121' ' ' GLU . 11.5 tttm -60.42 -42.47 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.981 -0.748 . . . . 2.58 108.981 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.27 -44.4 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 2.29 109.86 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.65 HH21 ' NE2' ' B' ' 351' ' ' GLN . 45.3 mtp180 -59.95 -40.13 87.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 2.55 108.63 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.72 63.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 1.21 109.043 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -39.96 79.41 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.548 -0.72 . . . . 1.18 109.144 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.79 -40.15 91.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 1.26 109.875 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -65.86 -39.9 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 1.13 109.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -59.79 -40.19 87.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 3.65 109.446 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.21 -38.34 83.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.772 . . . . 1.19 110.012 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.77 -46.63 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 1.13 111.043 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.45 61.9 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.751 -1.214 . . . . 0.4 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -59.59 -50.24 74.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -1.097 . . . . 3.15 109.721 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.528 HH12 ' HB3' ' A' ' 166' ' ' SER . 15.7 mtp180 -71.44 -26.05 62.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.0 -1.062 . . . . 3.84 110.124 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 tp -58.95 -44.19 91.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.716 -1.216 . . . . 1.23 107.716 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.1 mt -60.13 -39.55 86.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 1.32 109.032 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -69.1 -39.71 78.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.264 -0.898 . . . . 3.12 109.433 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.79 -38.16 84.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.62 -0.675 . . . . 1.46 110.864 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.0 mt -72.3 -44.45 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.676 -1.265 . . . . 1.09 108.144 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.554 -0.716 . . . . 1.18 109.744 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 42.39 9.03 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.923 -1.671 . . . . 0.52 108.923 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.5 145.96 43.1 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.626 -0.926 . . . . 1.29 110.666 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -61.96 141.79 57.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.8 109.831 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.36 126.51 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.604 -0.887 . . . . 1.26 108.604 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.0 mm -57.04 -46.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 1.73 110.025 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 69.03 96.34 0.06 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.956 -0.757 . . . . 1.29 108.956 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.74 -1.52 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 1.29 110.656 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -14.34 54.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.485 -1.384 . . . . 2.02 109.593 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 27.45 0.54 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.09 -1.007 . . . . 1.29 112.679 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.2 mm -88.65 122.54 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.289 -1.507 . . . . 1.93 109.837 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -99.16 -12.78 20.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.345 -0.847 . . . . 2.57 109.983 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -128.9 150.45 50.36 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.145 -0.972 . . . . 1.28 110.711 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.93 137.8 58.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.19 109.452 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -153.01 166.9 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.417 -0.802 . . . . 1.14 110.057 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.89 148.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.541 -2.022 . . . . 1.11 105.541 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.81 119.9 39.33 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.723 -1.236 . . . . 1.14 110.116 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 t -122.78 131.4 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.817 -0.808 . . . . 1.12 108.817 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.62 164.8 35.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 1.09 109.119 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.53 74.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.079 -1.638 . . . . 1.17 107.036 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.38 174.86 13.5 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.278 -1.008 . . . . 2.01 108.278 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -138.56 129.02 26.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 1.35 109.28 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.1 p -90.7 141.0 26.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 1.25 109.088 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.435 ' O ' ' OG1' ' A' ' 168' ' ' THR . 91.0 Cg_exo -39.25 -34.57 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.002 1.801 . . . . 0.75 112.731 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.528 ' HB3' HH12 ' A' ' 136' ' ' ARG . 11.3 m -63.69 -44.31 94.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.66 111.544 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -40.44 89.1 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.701 -1.249 . . . . 1.23 108.637 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 19.6 p -55.53 -36.87 67.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.675 -0.641 . . . . 1.18 111.154 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.03 71.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.717 -1.239 . . . . 1.16 109.111 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -92.92 37.66 1.02 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.66 108.204 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.65 137.34 43.66 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.64 -0.874 . . . . 1.21 108.64 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -86.36 102.9 14.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.083 -1.011 . . . . 2.88 108.644 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.33 -40.09 85.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.19 110.99 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -70.17 -29.65 66.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 2.4 111.551 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -94.11 -6.4 45.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.858 -1.151 . . . . 2.5 110.106 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 77.8 t -101.45 114.34 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.612 -1.255 . . . . 1.13 107.612 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.56 10.11 11.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.102 -0.999 . . . . 1.17 110.918 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.402 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 162.3 -179.47 37.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.028 -1.629 . . . . 0.33 109.028 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -139.89 132.87 29.41 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.968 -1.123 . . . . 0.37 107.968 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.01 126.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.179 -1.045 . . . . 1.13 108.179 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.4 p -145.26 157.47 44.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.881 -1.137 . . . . 1.19 110.361 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -105.09 25.89 9.99 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.751 -0.833 . . . . 2.01 108.751 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.0 -160.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.225 -0.922 . . . . 1.2 111.401 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.71 -54.48 5.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.897 -0.881 . . . . 0.68 110.897 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -138.63 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.128 -1.51 . . . . 0.73 110.238 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -69.75 -20.98 63.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 4.17 108.811 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.9 p -60.26 -4.29 0.8 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.615 -0.883 . . . . 1.53 108.615 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 186' ' ' ARG . 9.5 t -91.04 129.18 37.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.683 -0.858 . . . . 1.87 108.683 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 1.263 ' NE2' ' P ' ' B' ' 600' ' ' PO3 . 33.2 t-80 -60.07 -36.73 77.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.681 -1.262 . . . . 0.48 107.668 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.48 ' HG1' ' HG ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -57.16 -38.59 73.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 2.13 109.226 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.4 t -52.57 -30.67 32.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.682 -1.261 . . . . 1.81 108.748 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.2 mt -69.88 -35.01 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.249 -1.019 . . . . 1.96 108.249 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.8 mtp -58.9 -44.7 91.25 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.023 -1.071 . . . . 1.24 109.981 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.48 94.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.822 -1.174 . . . . 1.13 110.095 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -63.32 -52.98 59.61 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.24 -0.913 . . . . 3.53 110.05 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.3 m -60.25 -39.61 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.689 -1.257 . . . . 1.02 110.35 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.77 -28.62 66.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.069 -1.085 . . . . 1.22 108.069 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 67.24 48.84 1.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.006 0.432 . . . . 1.27 109.924 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 8' ' ' SER . 35.2 mt -127.8 144.69 52.19 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.535 -0.728 . . . . 1.22 109.15 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.87 132.05 8.09 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.712 2.275 . . . . 0.91 113.07 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.31 143.76 4.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.288 -1.507 . . . . 1.24 112.609 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -123.66 146.64 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 107.492 -1.299 . . . . 1.18 107.492 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.84 -5.81 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.421 -0.799 . . . . 1.21 110.417 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.25 21.77 19.21 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 121.505 -0.747 . . . . 0.56 111.249 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 p -46.06 -42.93 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.805 -1.409 . . . . 1.18 110.029 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.48 -53.52 3.1 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.058 -1.068 . . . . 0.6 111.592 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -155.5 32.09 0.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.452 -1.617 . . . . 1.87 111.617 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.42 -39.86 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 1.15 108.833 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.458 ' HG1' ' N ' ' A' ' 210' ' ' SER . 53.1 p -54.41 -30.24 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 1.23 110.496 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.458 ' N ' ' HG1' ' A' ' 209' ' ' THR . 61.4 m -83.46 -15.33 50.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 1.93 110.668 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -101.03 -13.64 18.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.896 . . . . 2.69 110.153 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.3 t -106.99 142.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.437 -0.79 . . . . 1.46 109.956 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 213' ' ' LYS . 2.0 mptp? -110.47 165.62 11.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.441 -2.059 . . . . 2.81 105.441 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.7 p-10 -70.39 148.55 48.26 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 119.798 -1.814 . . . . 2.8 109.8 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.2 t0 80.65 6.99 1.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.657 -0.652 . . . . 2.05 110.38 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.95 147.95 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.933 -1.104 . . . . 1.99 108.218 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -94.71 120.47 34.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.984 -1.073 . . . . 0.99 108.681 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.8 mt -128.41 144.89 51.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.452 -0.78 . . . . 1.25 110.909 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.8 mt -114.63 129.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.041 -1.466 . . . . 1.17 107.041 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.8 tp -104.68 120.3 41.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.93 . . . . 1.18 109.233 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 223' ' ' VAL . 73.0 m-20 -78.58 -38.91 39.02 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.527 -0.916 . . . . 1.89 108.527 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.2 15.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.705 -0.85 . . . . 1.21 108.705 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.0 t -131.83 -43.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.297 -1.372 . . . . 1.23 107.297 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.04 -0.02 39.99 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.398 -1.334 . . . . 2.74 107.398 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 60.43 41.37 16.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 2.03 109.668 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -131.61 148.29 52.59 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.527 -0.733 . . . . 1.93 109.844 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.33 129.82 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 1.19 108.097 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -100.6 121.23 41.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 1.3 109.253 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.31 114.87 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.452 -0.78 . . . . 1.18 110.409 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 230' ' ' ASN . 27.2 t-20 54.33 67.36 3.46 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.243 -0.91 . . . . 2.18 110.978 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.32 144.09 2.64 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.037 2.491 . . . . 0.86 112.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 22.2 p -71.12 169.16 15.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 2.19 110.325 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.74 -39.73 85.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 3.16 109.827 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -37.37 78.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 2.56 109.908 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.58 -39.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.062 -1.024 . . . . 1.5 108.405 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt -67.42 -47.66 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.39 -0.819 . . . . 1.33 109.373 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 2.44 108.49 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -69.29 -39.72 78.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 2.76 109.005 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.4 mtp -74.63 -29.5 61.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 1.29 109.369 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -39.95 77.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 3.32 109.531 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.21 92.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.795 . . . . 1.6 109.103 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.37 -43.61 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 1.69 108.779 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.26 -39.78 87.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 2.71 109.369 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -60.16 -39.83 87.75 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.268 -1.012 . . . . 1.95 108.268 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.02 -39.68 86.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.639 -0.875 . . . . 2.97 108.639 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.49 -43.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 1.97 109.046 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.03 87.89 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.811 -0.811 . . . . 2.1 108.811 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -40.18 87.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 2.84 109.075 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.358 -0.839 . . . . 3.29 108.8 179.479 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.087 -0.708 . . . . 2.16 109.087 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -152.36 149.96 29.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.89 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -149.61 158.91 44.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.961 -1.087 . . . . 2.16 110.805 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -152.36 148.7 27.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.022 -0.733 . . . . 2.51 109.022 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 129.83 55.62 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.064 -1.022 . . . . 2.08 109.518 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -130.69 122.44 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-O 122.302 1.048 . . . . 1.11 112.509 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.5 m -77.15 104.48 7.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.755 0.788 . . . . 1.16 110.921 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 41.6 mt -52.66 122.17 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 122.514 1.149 . . . . 1.18 110.894 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.3 p -108.67 19.48 19.65 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.938 -1.028 . . . . 1.27 110.283 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.99 116.58 55.44 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.853 -1.165 . . . . 1.22 107.853 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.37 -14.0 6.14 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.707 1.288 . . . . 1.19 113.922 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -120.75 14.86 11.77 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.175 -0.953 . . . . 0.91 109.326 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.94 177.82 45.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.711 -1.756 . . . . 0.53 108.711 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.503 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -81.19 87.02 6.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.91 -1.347 . . . . 1.14 108.701 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 1.221 ' ND1' ' P ' ' B' ' 600' ' ' PO3 . 1.6 p80 -85.73 -168.19 2.14 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.718 -1.239 . . . . 0.38 110.565 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.5 m -56.1 -41.86 75.89 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.238 -0.914 . . . . 1.06 111.277 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 67' ' ' GLU . 10.1 tpt180 -53.28 -62.18 3.91 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.756 -1.215 . . . . 2.44 111.23 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.96 -35.47 87.7 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 CA-C-N 120.217 1.113 . . . . 0.42 110.886 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.6 -53.32 59.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.99 -1.069 . . . . 1.1 108.984 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.44 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 1.08 109.3 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -71.24 -40.01 71.3 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.802 -1.159 . . . . 2.66 108.616 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -60.7 -51.72 68.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.905 . . . . 0.61 110.731 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.35 -29.79 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.524 -1.36 . . . . 1.07 109.319 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.544 ' HZ2' ' CD ' ' A' ' 74' ' ' GLU . 22.2 ttmt -61.0 -45.39 94.99 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.45 -0.9 . . . . 2.15 109.515 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.65 -49.9 71.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -0.972 . . . . 1.88 110.096 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.92 63.18 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.971 -1.081 . . . . 1.15 110.965 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -52.88 -14.03 0.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.707 -1.246 . . . . 1.87 109.541 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.2 74.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.502 . . . . 0.85 109.346 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -105.98 141.78 36.79 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.969 . . . . 0.91 109.195 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.1 m -90.16 -10.81 43.13 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 2.17 109.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -63.85 153.51 36.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.33 -0.856 . . . . 1.84 110.097 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.71 132.54 46.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 2.6 108.794 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.37 131.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.005 -0.739 . . . . 1.16 109.005 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.7 m -129.28 148.43 51.21 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.818 -0.808 . . . . 1.15 108.818 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.95 115.37 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.966 -1.494 . . . . 1.21 106.966 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.7 m -103.57 125.5 50.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.823 -1.173 . . . . 1.21 109.827 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.3 t -135.68 120.36 18.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.603 -0.686 . . . . 1.84 109.99 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' B' ' 340' ' ' LYS . 6.8 m-20 41.64 70.8 0.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.645 -0.659 . . . . 2.92 111.102 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 59.89 -8.51 0.05 OUTLIER Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.541 -1.35 . . . . 0.97 112.709 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' B' ' 338' ' ' ASN . 10.5 mttp -109.8 121.74 45.91 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 118.949 1.375 . . . . 2.96 109.599 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.52 147.41 48.41 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.286 -0.884 . . . . 1.74 110.797 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.07 165.75 26.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.588 -0.695 . . . . 1.15 110.408 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.33 131.32 34.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.48 -0.763 . . . . 1.66 111.065 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.35 -14.77 62.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.018 . . . . 1.08 111.061 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -96.46 21.58 9.01 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.807 -1.553 . . . . 2.98 106.807 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 1.4 t -140.8 91.85 2.45 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.693 -1.139 . . . . 1.87 111.311 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.449 ' O ' ' OE1' ' B' ' 351' ' ' GLN . 51.4 tp -60.24 -36.33 77.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.967 -0.753 . . . . 1.18 108.967 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -56.05 -51.95 66.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.858 -1.151 . . . . 0.36 110.37 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -70.08 -41.24 74.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.709 -1.244 . . . . 1.85 110.73 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.1 mt -48.12 -55.39 10.39 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.774 -1.204 . . . . 1.12 108.291 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.65 ' NE2' HH21 ' A' ' 126' ' ' ARG . 1.2 mp0 -37.68 -21.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.949 -0.47 . . . . 2.25 111.241 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.8 p -86.4 -10.22 54.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.767 -1.208 . . . . 1.15 110.342 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.83 116.11 28.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 1.14 109.395 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.73 92.86 0.81 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.218 -1.553 . . . . 0.5 109.218 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.64 92.0 4.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.282 -1.128 . . . . 1.2 110.305 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.3 p -93.39 179.99 5.23 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.932 -1.105 . . . . 1.18 111.332 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.53 112.02 6.48 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.512 -0.742 . . . . 2.67 110.525 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.74 10.86 31.95 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.345 -1.502 . . . . 0.81 109.345 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 79.3 m -90.39 109.64 20.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -1.174 . . . . 1.17 110.845 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.14 116.77 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.215 1.007 . . . . 1.17 108.899 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.54 175.56 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.748 -1.205 . . . . 1.16 107.748 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.6 m -131.73 127.48 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.438 -1.319 . . . . 1.2 107.438 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.39 118.14 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.131 -1.433 . . . . 1.16 107.131 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.04 131.39 55.09 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.622 -0.881 . . . . 1.7 108.622 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -142.48 149.09 38.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -0.92 . . . . 1.19 109.499 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -143.36 121.16 11.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.621 -0.881 . . . . 1.88 108.621 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.38 -159.58 30.98 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.097 -1.525 . . . . 0.86 111.334 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -60.23 -50.31 74.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.154 -0.616 . . . . 2.15 111.645 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -106.3 9.68 31.9 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.755 -1.216 . . . . 1.44 111.967 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -41.09 -33.73 0.37 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.895 -1.128 . . . . 2.2 111.862 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.51 -43.75 69.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.077 -1.014 . . . . 2.81 110.948 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -67.95 -48.5 65.71 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.46 -0.896 . . . . 2.68 109.0 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.58 -77.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.326 -0.859 . . . . 1.28 110.03 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 60.6 t -44.6 -38.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.298 -0.876 . . . . 1.27 110.822 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -70.11 -39.66 75.35 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.317 -1.49 . . . . 2.19 110.593 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.01 -47.97 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.784 -1.197 . . . . 2.24 109.93 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.96 -35.52 75.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 1.2 109.522 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 28.7 t -64.21 -41.83 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 1.18 109.175 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -70.4 -57.76 4.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.727 -1.212 . . . . 2.58 107.727 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.85 -29.39 41.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 1.26 110.358 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.1 ttm -77.45 -35.93 53.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.737 -1.227 . . . . 2.15 108.18 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.34 -9.99 59.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.491 -0.756 . . . . 1.5 110.54 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -110.13 0.0 18.11 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.985 -1.072 . . . . 2.24 111.368 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.13 128.59 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.378 -1.451 . . . . 1.81 109.433 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.735 -1.126 . . . . 2.62 109.285 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 600' ' ' PO3 . . . . . 1.263 ' P ' ' NE2' ' A' ' 189' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.161 -0.681 . . . . 3.52 109.161 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -95.65 122.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 1.13 108.95 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -130.04 139.79 50.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.564 -0.71 . . . . 0.86 109.931 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.44 -164.07 12.18 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.442 -1.863 . . . . 0.6 108.442 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.7 mt -90.22 -13.17 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.703 -1.469 . . . . 0.71 110.546 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.2 tp 52.45 102.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.071 -1.018 . . . . 0.65 109.245 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.87 -31.02 13.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.81 109.352 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 6.0 m -131.26 122.68 19.22 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.686 . . . . 1.45 109.152 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.83 145.78 16.1 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.755 1.637 . . . . 0.61 112.195 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.38 -160.3 31.22 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 108.978 -1.649 . . . . 0.55 108.978 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -147.62 150.08 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 120.871 -1.37 . . . . 0.54 108.049 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.73 154.04 32.22 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.576 -1.328 . . . . 0.38 110.617 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.1 m-85 -133.19 127.24 33.36 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.172 -1.047 . . . . 0.54 108.172 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.73 179.93 48.06 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.548 -1.787 . . . . 0.37 111.072 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -80.09 158.39 26.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.698 -0.883 . . . . 1.69 109.4 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.48 127.06 52.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.5 -0.75 . . . . 0.37 110.986 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.76 138.15 36.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.44 106.953 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -119.44 124.36 46.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.353 -0.842 . . . . 0.53 109.259 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.06 104.39 15.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.75 110.427 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -98.73 128.91 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.481 -0.762 . . . . 1.82 109.263 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -131.11 132.89 45.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.291 -0.881 . . . . 2.32 109.503 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -74.84 147.29 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.81 -1.182 . . . . 2.08 109.145 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.14 142.03 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 1.93 109.272 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.93 130.0 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -0.807 . . . . 0.58 109.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.25 128.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.285 -0.884 . . . . 0.58 109.507 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.84 137.31 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.489 -0.757 . . . . 0.5 109.045 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.32 119.47 32.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 1.24 109.435 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -89.99 0.09 57.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.613 -0.884 . . . . 2.89 108.613 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.43 139.95 58.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 1.92 109.166 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -84.24 150.14 25.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.735 -1.228 . . . . 2.34 109.753 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.04 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.492 -0.755 . . . . 0.47 109.84 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -96.9 174.33 6.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.63 108.529 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.06 79.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.64 109.442 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -55.11 -30.27 59.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.546 -1.346 . . . . 2.34 109.32 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.65 -9.95 59.16 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.21 -0.931 . . . . 1.02 110.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -64.07 -53.36 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.706 -1.247 . . . . 0.44 108.266 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.76 -40.19 91.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.184 -0.948 . . . . 1.24 110.119 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -68.8 -40.3 79.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 2.09 110.93 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.9 mm-40 -65.18 -40.24 93.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.795 -1.191 . . . . 1.23 109.81 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.98 -45.96 94.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.991 -1.114 . . . . 0.52 107.991 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.36 -40.8 92.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.12 . . . . 1.35 109.48 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -60.04 -43.44 95.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.65 -1.22 . . . . 2.82 107.761 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 89' ' ' ILE . 54.8 t80 -60.54 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.626 -0.879 . . . . 0.72 108.626 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -60.17 -47.37 86.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.503 -0.748 . . . . 0.7 109.362 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -64.99 -43.35 92.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.162 -0.961 . . . . 0.69 109.139 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.67 -45.24 96.2 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.407 -1.877 . . . . 0.46 108.407 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -65.99 -37.94 87.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -1.054 . . . . 2.71 108.824 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.1 62.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.541 -0.911 . . . . 0.63 108.541 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -64.62 -74.9 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.47 -1.308 . . . . 2.24 107.47 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.57 -36.86 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.478 -0.764 . . . . 0.39 111.463 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -55.12 -57.94 9.68 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.778 -1.201 . . . . 1.42 108.745 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.06 76.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.51 111.461 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.57 -40.47 88.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.625 -1.297 . . . . 1.17 110.259 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.17 -40.0 95.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.41 108.999 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' OE2' HD13 ' A' ' 77' ' ' ILE . 67.5 mm-40 -60.25 -37.35 80.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.17 109.895 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.5 m -65.07 -41.34 95.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.001 -1.062 . . . . 0.46 109.419 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -62.7 -38.96 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.42 108.838 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -57.95 -50.01 74.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.288 -0.883 . . . . 1.0 109.591 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -59.5 -34.05 72.12 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.379 -0.825 . . . . 0.46 109.915 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.16 -38.49 78.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 1.72 109.379 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.03 97.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.631 -0.668 . . . . 0.4 109.52 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.13 -55.83 21.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.657 -1.377 . . . . 0.43 109.657 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -59.89 -48.89 79.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.124 -1.221 . . . . 1.21 109.532 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -68.09 -58.02 5.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.45 111.716 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -95.94 -58.02 2.2 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.015 -1.053 . . . . 0.46 111.299 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.49 -170.01 25.27 Favored Glycine 0 N--CA 1.501 2.983 0 C-N-CA 119.781 -1.2 . . . . 0.38 111.213 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' O ' ' NH1' ' B' ' 317' ' ' ARG . 40.9 tt0 -70.32 -26.06 63.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.072 -0.663 . . . . 1.27 110.586 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -63.56 -36.06 82.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 1.33 110.64 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -101.0 -23.61 14.48 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.017 -1.052 . . . . 0.55 109.886 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -63.97 -40.18 95.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.135 -0.978 . . . . 1.18 110.44 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HB3' HH11 ' B' ' 317' ' ' ARG . . . -63.67 -29.51 70.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.38 109.98 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.04 -40.81 84.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.971 -1.122 . . . . 0.51 107.971 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 52.3 m-85 -66.74 -39.86 88.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 1.04 110.209 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -59.82 -40.24 87.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.001 -1.062 . . . . 1.21 109.53 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.52 -45.5 92.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.77 -1.732 . . . . 0.28 108.77 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -60.16 -43.4 95.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.54 109.2 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.5 mt -69.13 -46.27 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.026 . . . . 0.4 109.122 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.5 ttp -60.37 -43.13 96.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.32 110.082 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.8 tp -61.41 -40.1 93.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.147 -0.971 . . . . 0.31 109.309 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.11 -39.89 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.794 -0.567 . . . . 0.37 110.073 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.54 4.29 21.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.999 -1.063 . . . . 1.23 110.108 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.89 130.38 21.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.129 -0.982 . . . . 1.2 109.619 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.22 -19.49 54.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.59 -0.694 . . . . 1.32 110.897 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.16 -34.13 70.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.064 . . . . 1.24 108.869 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.9 -41.73 74.33 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.479 0.657 . . . . 0.32 109.533 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.13 -48.16 82.87 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.155 -0.966 . . . . 1.19 110.236 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.68 -40.29 76.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.7 111.52 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.91 -39.49 72.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.947 -1.095 . . . . 1.29 111.89 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 43' ' ' PHE . 94.9 mt -69.29 -44.77 80.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.04 -1.038 . . . . 0.37 108.784 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -68.2 -38.99 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.774 . . . . 0.48 110.519 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.27 91.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.102 . . . . 0.48 110.581 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.14 -47.41 86.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.893 -1.129 . . . . 0.51 110.005 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.6 mt -61.52 -49.29 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.918 0.866 . . . . 0.44 108.998 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -68.61 -42.8 77.62 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.919 -0.712 . . . . 1.76 110.69 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -81.13 -51.9 7.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.062 -1.024 . . . . 1.27 112.17 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -90.62 -1.9 57.87 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.062 -1.024 . . . . 1.88 112.417 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 57.12 37.78 28.7 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.825 -1.172 . . . . 1.34 109.47 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.0 mtp -90.7 165.82 13.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.735 -0.603 . . . . 1.43 109.714 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.6 p -79.9 161.73 25.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.43 108.904 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.78 -39.02 80.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.42 110.005 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.28 -39.14 92.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.003 -1.061 . . . . 2.14 110.034 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.44 -40.05 27.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.37 110.157 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.72 47.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.38 110.328 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -39.76 88.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.956 -1.09 . . . . 0.37 110.118 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.6 t60 -60.52 -40.55 91.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -0.991 . . . . 0.69 109.853 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -62.08 -39.85 93.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.169 -0.957 . . . . 1.24 110.274 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.74 -53.9 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 0.35 111.709 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.39 -40.04 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.826 -1.171 . . . . 0.38 108.677 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.489 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.71 -39.74 94.17 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.204 -1.036 . . . . 1.99 108.204 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.79 95.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.905 -1.278 . . . . 0.39 109.905 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -69.87 -52.22 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.791 -1.417 . . . . 1.16 109.415 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.97 -39.9 79.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.47 108.901 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.9 t -59.14 -39.98 84.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.242 -0.911 . . . . 1.36 108.68 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.39 90.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.53 109.174 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' B' ' 351' ' ' GLN . 35.9 mt -65.34 -40.23 93.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.971 -1.081 . . . . 0.57 109.992 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.96 -29.49 68.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.69 -1.256 . . . . 1.6 109.558 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.93 -22.34 62.32 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.606 -0.887 . . . . 1.46 108.606 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 146.13 51.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.436 -0.95 . . . . 0.64 108.436 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.22 17.09 13.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.09 -1.006 . . . . 2.26 110.461 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.2 t0 -108.27 142.89 37.88 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.217 -0.927 . . . . 1.26 109.863 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 124' ' ' LYS . 25.4 mt-10 -73.03 -60.41 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.509 -1.293 . . . . 2.58 107.509 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.503 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 5.4 t80 -37.17 -41.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.905 -0.589 . . . . 0.78 110.953 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 mt -78.6 -32.12 47.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.524 -1.36 . . . . 0.5 108.364 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 121' ' ' GLU . 11.5 tttm -60.42 -42.47 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.981 -0.748 . . . . 2.04 108.981 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 79.8 mt-10 -63.27 -44.4 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 2.29 109.86 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.669 HH21 ' NE2' ' B' ' 351' ' ' GLN . 45.3 mtp180 -59.95 -40.13 87.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 1.85 108.63 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.72 63.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.56 109.043 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -68.9 -39.96 79.41 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.548 -0.72 . . . . 0.63 109.144 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.79 -40.15 91.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 1.26 109.875 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -65.86 -39.9 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 0.36 109.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -59.79 -40.19 87.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 3.14 109.446 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.21 -38.34 83.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.772 . . . . 1.19 110.012 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.77 -46.63 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.4 111.043 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.45 61.9 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.751 -1.214 . . . . 0.34 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -59.59 -50.24 74.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -1.097 . . . . 2.67 109.721 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' A' ' 166' ' ' SER . 15.7 mtp180 -71.44 -26.05 62.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.0 -1.062 . . . . 3.25 110.124 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 tp -58.95 -44.19 91.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.716 -1.216 . . . . 0.46 107.716 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.1 mt -60.13 -39.55 86.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.6 109.032 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -69.1 -39.71 78.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.264 -0.898 . . . . 2.58 109.433 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.79 -38.16 84.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.62 -0.675 . . . . 1.46 110.864 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.0 mt -72.3 -44.45 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.676 -1.265 . . . . 0.38 108.144 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.554 -0.716 . . . . 0.52 109.744 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 42.39 9.03 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.923 -1.671 . . . . 0.48 108.923 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.5 145.96 43.1 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.626 -0.926 . . . . 0.67 110.666 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -61.96 141.79 57.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.35 109.831 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.36 126.51 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.604 -0.887 . . . . 0.59 108.604 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 147' ' ' ILE . 11.0 mm -57.04 -46.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 1.11 110.025 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 69.03 96.34 0.06 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.956 -0.757 . . . . 1.29 108.956 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.74 -1.52 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.73 110.656 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -14.34 54.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.485 -1.384 . . . . 1.48 109.593 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 27.45 0.54 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.09 -1.007 . . . . 0.7 112.679 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.2 mm -88.65 122.54 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.289 -1.507 . . . . 1.34 109.837 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -99.16 -12.78 20.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.345 -0.847 . . . . 1.97 109.983 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -128.9 150.45 50.36 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.145 -0.972 . . . . 1.28 110.711 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.93 137.8 58.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.19 109.452 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -153.01 166.9 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.417 -0.802 . . . . 0.36 110.057 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.89 148.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.541 -2.022 . . . . 0.32 105.541 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.81 119.9 39.33 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.723 -1.236 . . . . 0.37 110.116 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 209' ' ' THR . 16.3 t -122.78 131.4 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.62 164.8 35.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.41 109.119 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.53 74.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.079 -1.638 . . . . 0.54 107.036 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.38 174.86 13.5 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.278 -1.008 . . . . 2.01 108.278 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -138.56 129.02 26.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.74 109.28 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.1 p -90.7 141.0 26.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 0.64 109.088 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -39.25 -34.57 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.002 1.801 . . . . 0.68 112.731 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB3' HH12 ' A' ' 136' ' ' ARG . 11.3 m -63.69 -44.31 94.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.56 111.544 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -40.44 89.1 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.701 -1.249 . . . . 1.23 108.637 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 p -55.53 -36.87 67.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.675 -0.641 . . . . 0.55 111.154 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -68.18 -46.03 71.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.717 -1.239 . . . . 0.47 109.111 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -92.92 37.66 1.02 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 62.3 tp -105.65 137.34 43.66 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.64 -0.874 . . . . 0.57 108.64 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' VAL . 6.4 m-20 -86.36 102.9 14.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.083 -1.011 . . . . 2.18 108.644 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.33 -40.09 85.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.53 110.99 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -70.17 -29.65 66.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.91 111.551 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -94.11 -6.4 45.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.858 -1.151 . . . . 1.98 110.106 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.8 t -101.45 114.34 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.612 -1.255 . . . . 0.37 107.612 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.56 10.11 11.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.102 -0.999 . . . . 0.45 110.918 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.527 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 162.3 -179.47 37.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.028 -1.629 . . . . 0.31 109.028 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 176' ' ' VAL . 4.8 m-85 -139.89 132.87 29.41 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.968 -1.123 . . . . 0.34 107.968 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 56.4 mt -131.01 126.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.179 -1.045 . . . . 0.41 108.179 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.4 p -145.26 157.47 44.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.881 -1.137 . . . . 0.5 110.361 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -105.09 25.89 9.99 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.751 -0.833 . . . . 2.01 108.751 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.0 -160.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.225 -0.922 . . . . 0.56 111.401 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.71 -54.48 5.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.897 -0.881 . . . . 0.68 110.897 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -138.63 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.128 -1.51 . . . . 0.64 110.238 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -69.75 -20.98 63.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 3.65 108.811 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.9 p -60.26 -4.29 0.8 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.615 -0.883 . . . . 1.09 108.615 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 9.5 t -91.04 129.18 37.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.683 -0.858 . . . . 1.34 108.683 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 1.263 ' NE2' ' P ' ' B' ' 600' ' ' PO3 . 33.2 t-80 -60.07 -36.73 77.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.681 -1.262 . . . . 0.45 107.668 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -38.59 73.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 1.49 109.226 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.4 t -52.57 -30.67 32.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.682 -1.261 . . . . 1.36 108.748 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 192' ' ' ILE . 20.2 mt -69.88 -35.01 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.249 -1.019 . . . . 1.33 108.249 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.8 mtp -58.9 -44.7 91.25 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.023 -1.071 . . . . 0.62 109.981 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.48 94.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.822 -1.174 . . . . 0.44 110.095 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -63.32 -52.98 59.61 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.24 -0.913 . . . . 2.98 110.05 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.3 m -60.25 -39.61 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.689 -1.257 . . . . 0.51 110.35 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.77 -28.62 66.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.069 -1.085 . . . . 0.47 108.069 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 67.24 48.84 1.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.006 0.432 . . . . 1.27 109.924 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 8' ' ' SER . 35.2 mt -127.8 144.69 52.19 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.535 -0.728 . . . . 0.49 109.15 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.87 132.05 8.09 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.712 2.275 . . . . 0.57 113.07 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.31 143.76 4.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.288 -1.507 . . . . 0.57 112.609 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -123.66 146.64 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 107.492 -1.299 . . . . 0.51 107.492 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.84 -5.81 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.421 -0.799 . . . . 0.53 110.417 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.25 21.77 19.21 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 121.505 -0.747 . . . . 0.53 111.249 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.7 p -46.06 -42.93 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.805 -1.409 . . . . 0.56 110.029 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.48 -53.52 3.1 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.058 -1.068 . . . . 0.59 111.592 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -155.5 32.09 0.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.452 -1.617 . . . . 1.41 111.617 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.42 -39.86 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.49 108.833 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.589 HG22 HG12 ' A' ' 159' ' ' VAL . 53.1 p -54.41 -30.24 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.63 110.496 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 61.4 m -83.46 -15.33 50.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 1.44 110.668 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -101.03 -13.64 18.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.896 . . . . 2.2 110.153 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.3 t -106.99 142.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.437 -0.79 . . . . 0.88 109.956 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 213' ' ' LYS . 2.0 mptp? -110.47 165.62 11.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.441 -2.059 . . . . 2.33 105.441 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.7 p-10 -70.39 148.55 48.26 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 119.798 -1.814 . . . . 2.1 109.8 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.2 t0 80.65 6.99 1.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.657 -0.652 . . . . 2.05 110.38 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.95 147.95 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.933 -1.104 . . . . 1.99 108.218 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -94.71 120.47 34.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.984 -1.073 . . . . 0.51 108.681 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -128.41 144.89 51.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.452 -0.78 . . . . 0.54 110.909 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.8 mt -114.63 129.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.041 -1.466 . . . . 0.43 107.041 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.8 tp -104.68 120.3 41.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.93 . . . . 0.53 109.233 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 223' ' ' VAL . 73.0 m-20 -78.58 -38.91 39.02 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.527 -0.916 . . . . 1.89 108.527 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.2 15.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.705 -0.85 . . . . 0.52 108.705 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.0 t -131.83 -43.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.297 -1.372 . . . . 0.61 107.297 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.04 -0.02 39.99 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.398 -1.334 . . . . 2.11 107.398 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 60.43 41.37 16.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 1.3 109.668 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -131.61 148.29 52.59 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.527 -0.733 . . . . 1.44 109.844 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.33 129.82 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.53 108.097 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -100.6 121.23 41.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.75 109.253 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.31 114.87 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.452 -0.78 . . . . 0.59 110.409 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 230' ' ' ASN . 27.2 t-20 54.33 67.36 3.46 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.243 -0.91 . . . . 1.48 110.978 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.32 144.09 2.64 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.037 2.491 . . . . 0.76 112.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 22.2 p -71.12 169.16 15.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 1.59 110.325 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.74 -39.73 85.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 2.49 109.827 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -37.37 78.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 2.56 109.908 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.58 -39.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.062 -1.024 . . . . 0.98 108.405 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt -67.42 -47.66 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.39 -0.819 . . . . 0.79 109.373 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 2.44 108.49 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -69.29 -39.72 78.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 2.29 109.005 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.4 mtp -74.63 -29.5 61.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.93 109.369 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -39.95 77.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 2.82 109.531 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.21 92.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.795 . . . . 1.19 109.103 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.37 -43.61 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 1.2 108.779 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.26 -39.78 87.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 2.07 109.369 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -60.16 -39.83 87.75 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.268 -1.012 . . . . 1.95 108.268 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.02 -39.68 86.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.639 -0.875 . . . . 2.48 108.639 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.49 -43.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 1.82 109.046 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.03 87.89 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.811 -0.811 . . . . 2.1 108.811 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -40.18 87.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 2.54 109.075 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.358 -0.839 . . . . 3.29 108.8 179.479 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.087 -0.708 . . . . 1.59 109.087 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -152.36 149.96 29.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.79 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -149.61 158.91 44.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.961 -1.087 . . . . 1.66 110.805 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -152.36 148.7 27.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.022 -0.733 . . . . 1.91 109.022 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 129.83 55.62 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.064 -1.022 . . . . 2.08 109.518 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -130.69 122.44 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-O 122.302 1.048 . . . . 0.43 112.509 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.416 ' O ' HG23 ' B' ' 309' ' ' THR . 48.5 m -77.15 104.48 7.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.755 0.788 . . . . 0.53 110.921 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 41.6 mt -52.66 122.17 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 122.514 1.149 . . . . 0.48 110.894 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.416 HG23 ' O ' ' B' ' 307' ' ' THR . 71.3 p -108.67 19.48 19.65 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.938 -1.028 . . . . 0.59 110.283 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.99 116.58 55.44 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.853 -1.165 . . . . 0.68 107.853 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.37 -14.0 6.14 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.707 1.288 . . . . 0.98 113.922 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -120.75 14.86 11.77 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.175 -0.953 . . . . 0.85 109.326 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.94 177.82 45.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.711 -1.756 . . . . 0.52 108.711 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.503 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -81.19 87.02 6.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.91 -1.347 . . . . 0.45 108.701 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 1.221 ' ND1' ' P ' ' B' ' 600' ' ' PO3 . 1.6 p80 -85.73 -168.19 2.14 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.718 -1.239 . . . . 0.36 110.565 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.5 m -56.1 -41.86 75.89 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.238 -0.914 . . . . 0.38 111.277 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 71' ' ' ALA . 10.1 tpt180 -53.28 -62.18 3.91 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.756 -1.215 . . . . 1.73 111.23 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.96 -35.47 87.7 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 CA-C-N 120.217 1.113 . . . . 0.39 110.886 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.6 -53.32 59.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.99 -1.069 . . . . 0.42 108.984 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.44 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.31 109.3 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.421 ' OE1' HD21 ' B' ' 384' ' ' LEU . 28.8 tt0 -71.24 -40.01 71.3 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.802 -1.159 . . . . 2.14 108.616 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -60.7 -51.72 68.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.905 . . . . 0.53 110.731 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 344' ' ' ALA . 57.5 t -65.35 -29.79 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.524 -1.36 . . . . 0.32 109.319 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -61.0 -45.39 94.99 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.45 -0.9 . . . . 1.57 109.515 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.65 -49.9 71.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -0.972 . . . . 1.88 110.096 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.92 63.18 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.971 -1.081 . . . . 0.59 110.965 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -52.88 -14.03 0.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.707 -1.246 . . . . 1.37 109.541 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.2 74.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.502 . . . . 0.79 109.346 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -105.98 141.78 36.79 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.969 . . . . 0.81 109.195 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.1 m -90.16 -10.81 43.13 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 1.59 109.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 83.9 p -63.85 153.51 36.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.33 -0.856 . . . . 1.38 110.097 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.71 132.54 46.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 2.6 108.794 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.37 131.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.005 -0.739 . . . . 0.53 109.005 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.7 m -129.28 148.43 51.21 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.818 -0.808 . . . . 0.51 108.818 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.95 115.37 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.966 -1.494 . . . . 0.59 106.966 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.7 m -103.57 125.5 50.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.823 -1.173 . . . . 0.56 109.827 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.3 t -135.68 120.36 18.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.603 -0.686 . . . . 1.36 109.99 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' B' ' 340' ' ' LYS . 6.8 m-20 41.64 70.8 0.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.645 -0.659 . . . . 2.35 111.102 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 59.89 -8.51 0.05 OUTLIER Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.541 -1.35 . . . . 0.86 112.709 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' B' ' 338' ' ' ASN . 10.5 mttp -109.8 121.74 45.91 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 118.949 1.375 . . . . 2.43 109.599 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.52 147.41 48.41 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.286 -0.884 . . . . 1.29 110.797 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.42 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.07 165.75 26.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.588 -0.695 . . . . 0.43 110.408 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.33 131.32 34.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.48 -0.763 . . . . 1.19 111.065 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.432 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.35 -14.77 62.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.018 . . . . 0.35 111.061 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -96.46 21.58 9.01 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.807 -1.553 . . . . 2.52 106.807 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 1.4 t -140.8 91.85 2.45 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.693 -1.139 . . . . 1.34 111.311 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.623 HD11 HE22 ' B' ' 351' ' ' GLN . 51.4 tp -60.24 -36.33 77.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.967 -0.753 . . . . 0.38 108.967 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.1 m-85 -56.05 -51.95 66.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.858 -1.151 . . . . 0.33 110.37 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -70.08 -41.24 74.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.709 -1.244 . . . . 1.28 110.73 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.1 mt -48.12 -55.39 10.39 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.774 -1.204 . . . . 0.42 108.291 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.669 ' NE2' HH21 ' A' ' 126' ' ' ARG . 1.2 mp0 -37.68 -21.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.949 -0.47 . . . . 2.08 111.241 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.8 p -86.4 -10.22 54.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.767 -1.208 . . . . 0.43 110.342 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 342' ' ' ALA . 65.3 mt -92.83 116.11 28.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.45 109.395 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.73 92.86 0.81 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.218 -1.553 . . . . 0.48 109.218 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.64 92.0 4.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.282 -1.128 . . . . 0.52 110.305 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.3 p -93.39 179.99 5.23 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.932 -1.105 . . . . 0.6 111.332 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.53 112.02 6.48 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.512 -0.742 . . . . 2.05 110.525 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.74 10.86 31.95 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.345 -1.502 . . . . 0.67 109.345 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 79.3 m -90.39 109.64 20.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -1.174 . . . . 0.63 110.845 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.14 116.77 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.215 1.007 . . . . 0.53 108.899 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.54 175.56 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.748 -1.205 . . . . 0.46 107.748 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.6 m -131.73 127.48 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.438 -1.319 . . . . 0.52 107.438 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.39 118.14 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.131 -1.433 . . . . 0.46 107.131 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.04 131.39 55.09 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.622 -0.881 . . . . 1.24 108.622 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -142.48 149.09 38.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -0.92 . . . . 0.62 109.499 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -143.36 121.16 11.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.621 -0.881 . . . . 1.88 108.621 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.38 -159.58 30.98 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.097 -1.525 . . . . 0.84 111.334 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -60.23 -50.31 74.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.154 -0.616 . . . . 2.15 111.645 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 11.4 m-20 -106.3 9.68 31.9 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.755 -1.216 . . . . 1.44 111.967 -177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -41.09 -33.73 0.37 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.895 -1.128 . . . . 2.2 111.862 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.51 -43.75 69.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.077 -1.014 . . . . 2.36 110.948 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -67.95 -48.5 65.71 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.46 -0.896 . . . . 2.18 109.0 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.58 -77.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.326 -0.859 . . . . 0.8 110.03 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.551 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.6 t -44.6 -38.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.298 -0.876 . . . . 0.65 110.822 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -70.11 -39.66 75.35 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.317 -1.49 . . . . 2.19 110.593 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.01 -47.97 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.784 -1.197 . . . . 1.56 109.93 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.96 -35.52 75.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.57 109.522 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.551 HG23 ' O ' ' B' ' 374' ' ' VAL . 28.7 t -64.21 -41.83 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.58 109.175 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -70.4 -57.76 4.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.727 -1.212 . . . . 2.13 107.727 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.85 -29.39 41.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.79 110.358 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.1 ttm -77.45 -35.93 53.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.737 -1.227 . . . . 1.74 108.18 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.34 -9.99 59.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.491 -0.756 . . . . 1.01 110.54 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -110.13 0.0 18.11 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.985 -1.072 . . . . 2.24 111.368 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.421 HD21 ' OE1' ' B' ' 321' ' ' GLN . 14.7 mt -85.13 128.59 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.378 -1.451 . . . . 1.3 109.433 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.735 -1.126 . . . . 2.62 109.285 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 600' ' ' PO3 . . . . . 1.263 ' P ' ' NE2' ' A' ' 189' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.161 -0.681 . . . . 3.52 109.161 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -95.65 122.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 1.13 108.95 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -130.04 139.79 50.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.564 -0.71 . . . . 0.86 109.931 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.44 -164.07 12.18 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.442 -1.863 . . . . 0.6 108.442 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.7 mt -90.22 -13.17 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.703 -1.469 . . . . 0.71 110.546 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.2 tp 52.45 102.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.071 -1.018 . . . . 0.65 109.245 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.87 -31.02 13.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.81 109.352 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 6.0 m -131.26 122.68 19.22 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.686 . . . . 1.45 109.152 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.83 145.78 16.1 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.755 1.637 . . . . 0.61 112.195 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.38 -160.3 31.22 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 108.978 -1.649 . . . . 0.55 108.978 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -147.62 150.08 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 O-C-N 120.871 -1.37 . . . . 0.54 108.049 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.73 154.04 32.22 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.576 -1.328 . . . . 0.38 110.617 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.1 m-85 -133.19 127.24 33.36 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.172 -1.047 . . . . 0.54 108.172 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.73 179.93 48.06 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.548 -1.787 . . . . 0.37 111.072 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -80.09 158.39 26.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.698 -0.883 . . . . 1.69 109.4 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.48 127.06 52.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.5 -0.75 . . . . 0.37 110.986 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.76 138.15 36.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.44 106.953 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -119.44 124.36 46.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.353 -0.842 . . . . 0.53 109.259 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.06 104.39 15.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.75 110.427 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -98.73 128.91 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.481 -0.762 . . . . 1.82 109.263 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -131.11 132.89 45.14 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.291 -0.881 . . . . 2.32 109.503 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -74.84 147.29 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.81 -1.182 . . . . 2.08 109.145 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.14 142.03 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 1.93 109.272 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.93 130.0 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -0.807 . . . . 0.58 109.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.25 128.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.285 -0.884 . . . . 0.58 109.507 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.84 137.31 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.489 -0.757 . . . . 0.5 109.045 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.32 119.47 32.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 1.24 109.435 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -89.99 0.09 57.29 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.613 -0.884 . . . . 2.89 108.613 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.43 139.95 58.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 1.92 109.166 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -84.24 150.14 25.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.735 -1.228 . . . . 2.34 109.753 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.04 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.492 -0.755 . . . . 0.47 109.84 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -96.9 174.33 6.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.63 108.529 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.06 79.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.64 109.442 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -55.11 -30.27 59.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.546 -1.346 . . . . 2.34 109.32 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.65 -9.95 59.16 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.21 -0.931 . . . . 1.02 110.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -64.07 -53.36 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.706 -1.247 . . . . 0.44 108.266 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.76 -40.19 91.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.184 -0.948 . . . . 1.24 110.119 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -68.8 -40.3 79.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 2.09 110.93 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.9 mm-40 -65.18 -40.24 93.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.795 -1.191 . . . . 1.23 109.81 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.98 -45.96 94.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.991 -1.114 . . . . 0.52 107.991 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.36 -40.8 92.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.12 . . . . 1.35 109.48 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -60.04 -43.44 95.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.65 -1.22 . . . . 2.82 107.761 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 89' ' ' ILE . 54.8 t80 -60.54 -49.63 76.79 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.626 -0.879 . . . . 0.72 108.626 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -60.17 -47.37 86.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.503 -0.748 . . . . 0.7 109.362 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -64.99 -43.35 92.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.162 -0.961 . . . . 0.69 109.139 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.67 -45.24 96.2 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.407 -1.877 . . . . 0.46 108.407 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -65.99 -37.94 87.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -1.054 . . . . 2.71 108.824 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.1 62.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.541 -0.911 . . . . 0.63 108.541 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -64.62 -74.9 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.47 -1.308 . . . . 2.24 107.47 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.57 -36.86 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.478 -0.764 . . . . 0.39 111.463 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -55.12 -57.94 9.68 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.778 -1.201 . . . . 1.42 108.745 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.06 76.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.51 111.461 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.57 -40.47 88.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.625 -1.297 . . . . 1.17 110.259 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.17 -40.0 95.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.41 108.999 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' OE2' HD13 ' A' ' 77' ' ' ILE . 67.5 mm-40 -60.25 -37.35 80.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.17 109.895 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.5 m -65.07 -41.34 95.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.001 -1.062 . . . . 0.46 109.419 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -62.7 -38.96 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.42 108.838 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -57.95 -50.01 74.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.288 -0.883 . . . . 1.0 109.591 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -59.5 -34.05 72.12 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.379 -0.825 . . . . 0.46 109.915 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.16 -38.49 78.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 1.72 109.379 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.03 97.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.631 -0.668 . . . . 0.4 109.52 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.13 -55.83 21.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.657 -1.377 . . . . 0.43 109.657 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -59.89 -48.89 79.86 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.124 -1.221 . . . . 1.21 109.532 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -68.09 -58.02 5.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.45 111.716 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -95.94 -58.02 2.2 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.015 -1.053 . . . . 0.46 111.299 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.49 -170.01 25.27 Favored Glycine 0 N--CA 1.501 2.983 0 C-N-CA 119.781 -1.2 . . . . 0.38 111.213 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' O ' ' NH1' ' B' ' 317' ' ' ARG . 40.9 tt0 -70.32 -26.06 63.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.072 -0.663 . . . . 1.27 110.586 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -63.56 -36.06 82.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 1.33 110.64 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -101.0 -23.61 14.48 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.017 -1.052 . . . . 0.55 109.886 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -63.97 -40.18 95.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.135 -0.978 . . . . 1.18 110.44 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HB3' HH11 ' B' ' 317' ' ' ARG . . . -63.67 -29.51 70.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.38 109.98 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.04 -40.81 84.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.971 -1.122 . . . . 0.51 107.971 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 52.3 m-85 -66.74 -39.86 88.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 1.04 110.209 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -59.82 -40.24 87.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.001 -1.062 . . . . 1.21 109.53 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.52 -45.5 92.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.77 -1.732 . . . . 0.28 108.77 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -60.16 -43.4 95.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -1.117 . . . . 0.54 109.2 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.5 mt -69.13 -46.27 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.026 . . . . 0.4 109.122 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.5 ttp -60.37 -43.13 96.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.32 110.082 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.8 tp -61.41 -40.1 93.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.147 -0.971 . . . . 0.31 109.309 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.11 -39.89 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.794 -0.567 . . . . 0.37 110.073 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.54 4.29 21.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.999 -1.063 . . . . 1.23 110.108 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.89 130.38 21.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.129 -0.982 . . . . 1.2 109.619 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.22 -19.49 54.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.59 -0.694 . . . . 1.32 110.897 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.16 -34.13 70.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.064 . . . . 1.24 108.869 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.9 -41.73 74.33 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.479 0.657 . . . . 0.32 109.533 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.13 -48.16 82.87 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.155 -0.966 . . . . 1.19 110.236 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.68 -40.29 76.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.7 111.52 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.91 -39.49 72.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.947 -1.095 . . . . 1.29 111.89 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 43' ' ' PHE . 94.9 mt -69.29 -44.77 80.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.04 -1.038 . . . . 0.37 108.784 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -68.2 -38.99 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.462 -0.774 . . . . 0.48 110.519 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.27 91.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.936 -1.102 . . . . 0.48 110.581 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.14 -47.41 86.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.893 -1.129 . . . . 0.51 110.005 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.6 mt -61.52 -49.29 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.918 0.866 . . . . 0.44 108.998 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -68.61 -42.8 77.62 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.919 -0.712 . . . . 1.76 110.69 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -81.13 -51.9 7.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.062 -1.024 . . . . 1.27 112.17 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -90.62 -1.9 57.87 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.062 -1.024 . . . . 1.88 112.417 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 57.12 37.78 28.7 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.825 -1.172 . . . . 1.34 109.47 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.0 mtp -90.7 165.82 13.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.735 -0.603 . . . . 1.43 109.714 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.6 p -79.9 161.73 25.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.43 108.904 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.78 -39.02 80.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.42 110.005 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.28 -39.14 92.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.003 -1.061 . . . . 2.14 110.034 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.44 -40.05 27.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.37 110.157 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.72 47.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.38 110.328 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -39.76 88.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.956 -1.09 . . . . 0.37 110.118 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.6 t60 -60.52 -40.55 91.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -0.991 . . . . 0.69 109.853 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -62.08 -39.85 93.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.169 -0.957 . . . . 1.24 110.274 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.74 -53.9 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 0.35 111.709 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.39 -40.04 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.826 -1.171 . . . . 0.38 108.677 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.489 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.71 -39.74 94.17 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.204 -1.036 . . . . 1.99 108.204 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.79 95.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.905 -1.278 . . . . 0.39 109.905 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -69.87 -52.22 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.791 -1.417 . . . . 1.16 109.415 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.97 -39.9 79.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.47 108.901 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.9 t -59.14 -39.98 84.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.242 -0.911 . . . . 1.36 108.68 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.39 90.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.53 109.174 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' B' ' 351' ' ' GLN . 35.9 mt -65.34 -40.23 93.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.971 -1.081 . . . . 0.57 109.992 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.96 -29.49 68.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.69 -1.256 . . . . 1.6 109.558 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.93 -22.34 62.32 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.606 -0.887 . . . . 1.46 108.606 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 146.13 51.34 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.436 -0.95 . . . . 0.64 108.436 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.22 17.09 13.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.09 -1.006 . . . . 2.26 110.461 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.2 t0 -108.27 142.89 37.88 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.217 -0.927 . . . . 1.26 109.863 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 124' ' ' LYS . 25.4 mt-10 -73.03 -60.41 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.509 -1.293 . . . . 2.58 107.509 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.503 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 5.4 t80 -37.17 -41.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.905 -0.589 . . . . 0.78 110.953 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 mt -78.6 -32.12 47.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.524 -1.36 . . . . 0.5 108.364 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 121' ' ' GLU . 11.5 tttm -60.42 -42.47 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.981 -0.748 . . . . 2.04 108.981 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 79.8 mt-10 -63.27 -44.4 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 2.29 109.86 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.669 HH21 ' NE2' ' B' ' 351' ' ' GLN . 45.3 mtp180 -59.95 -40.13 87.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 1.85 108.63 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.72 63.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.56 109.043 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -68.9 -39.96 79.41 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.548 -0.72 . . . . 0.63 109.144 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.79 -40.15 91.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 1.26 109.875 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -65.86 -39.9 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 0.36 109.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -59.79 -40.19 87.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.554 -0.716 . . . . 3.14 109.446 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.21 -38.34 83.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.772 . . . . 1.19 110.012 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.77 -46.63 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.4 111.043 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.45 61.9 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.751 -1.214 . . . . 0.34 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -59.59 -50.24 74.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -1.097 . . . . 2.67 109.721 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' A' ' 166' ' ' SER . 15.7 mtp180 -71.44 -26.05 62.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.0 -1.062 . . . . 3.25 110.124 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 tp -58.95 -44.19 91.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.716 -1.216 . . . . 0.46 107.716 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.1 mt -60.13 -39.55 86.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.466 -0.771 . . . . 0.6 109.032 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -69.1 -39.71 78.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.264 -0.898 . . . . 2.58 109.433 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.79 -38.16 84.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.62 -0.675 . . . . 1.46 110.864 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.0 mt -72.3 -44.45 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.676 -1.265 . . . . 0.38 108.144 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.554 -0.716 . . . . 0.52 109.744 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 42.39 9.03 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.923 -1.671 . . . . 0.48 108.923 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.5 145.96 43.1 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.626 -0.926 . . . . 0.67 110.666 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -61.96 141.79 57.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.35 109.831 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.36 126.51 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.604 -0.887 . . . . 0.59 108.604 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 147' ' ' ILE . 11.0 mm -57.04 -46.29 84.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 1.11 110.025 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 69.03 96.34 0.06 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.956 -0.757 . . . . 1.29 108.956 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.74 -1.52 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.73 110.656 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.96 -14.34 54.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.485 -1.384 . . . . 1.48 109.593 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 27.45 0.54 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.09 -1.007 . . . . 0.7 112.679 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.2 mm -88.65 122.54 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.289 -1.507 . . . . 1.34 109.837 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -99.16 -12.78 20.16 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.345 -0.847 . . . . 1.97 109.983 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -128.9 150.45 50.36 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.145 -0.972 . . . . 1.28 110.711 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.93 137.8 58.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.19 109.452 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -153.01 166.9 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.417 -0.802 . . . . 0.36 110.057 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.89 148.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.541 -2.022 . . . . 0.32 105.541 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.7 tp -100.81 119.9 39.33 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.723 -1.236 . . . . 0.37 110.116 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 209' ' ' THR . 16.3 t -122.78 131.4 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.62 164.8 35.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.41 109.119 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.53 74.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.079 -1.638 . . . . 0.54 107.036 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -160.38 174.86 13.5 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.278 -1.008 . . . . 2.01 108.278 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -138.56 129.02 26.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.74 109.28 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.1 p -90.7 141.0 26.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 0.64 109.088 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -39.25 -34.57 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.002 1.801 . . . . 0.68 112.731 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB3' HH12 ' A' ' 136' ' ' ARG . 11.3 m -63.69 -44.31 94.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.989 . . . . 0.56 111.544 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -40.44 89.1 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.701 -1.249 . . . . 1.23 108.637 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 p -55.53 -36.87 67.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.675 -0.641 . . . . 0.55 111.154 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -68.18 -46.03 71.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.717 -1.239 . . . . 0.47 109.111 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -92.92 37.66 1.02 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 62.3 tp -105.65 137.34 43.66 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.64 -0.874 . . . . 0.57 108.64 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' VAL . 6.4 m-20 -86.36 102.9 14.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.083 -1.011 . . . . 2.18 108.644 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.33 -40.09 85.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.53 110.99 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -70.17 -29.65 66.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.91 111.551 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -94.11 -6.4 45.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.858 -1.151 . . . . 1.98 110.106 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.8 t -101.45 114.34 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.612 -1.255 . . . . 0.37 107.612 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.56 10.11 11.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.102 -0.999 . . . . 0.45 110.918 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.527 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 162.3 -179.47 37.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.028 -1.629 . . . . 0.31 109.028 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 176' ' ' VAL . 4.8 m-85 -139.89 132.87 29.41 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.968 -1.123 . . . . 0.34 107.968 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 56.4 mt -131.01 126.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.179 -1.045 . . . . 0.41 108.179 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.4 p -145.26 157.47 44.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.881 -1.137 . . . . 0.5 110.361 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -105.09 25.89 9.99 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.751 -0.833 . . . . 2.01 108.751 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.0 -160.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.225 -0.922 . . . . 0.56 111.401 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.71 -54.48 5.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.897 -0.881 . . . . 0.68 110.897 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -138.63 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.128 -1.51 . . . . 0.64 110.238 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -69.75 -20.98 63.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 3.65 108.811 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.9 p -60.26 -4.29 0.8 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.615 -0.883 . . . . 1.09 108.615 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 9.5 t -91.04 129.18 37.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.683 -0.858 . . . . 1.34 108.683 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 1.263 ' NE2' ' P ' ' B' ' 600' ' ' PO3 . 33.2 t-80 -60.07 -36.73 77.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.681 -1.262 . . . . 0.45 107.668 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -38.59 73.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 1.49 109.226 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.4 t -52.57 -30.67 32.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.682 -1.261 . . . . 1.36 108.748 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 192' ' ' ILE . 20.2 mt -69.88 -35.01 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.249 -1.019 . . . . 1.33 108.249 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.8 mtp -58.9 -44.7 91.25 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.023 -1.071 . . . . 0.62 109.981 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.48 94.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.822 -1.174 . . . . 0.44 110.095 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -63.32 -52.98 59.61 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.24 -0.913 . . . . 2.98 110.05 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.3 m -60.25 -39.61 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.689 -1.257 . . . . 0.51 110.35 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.77 -28.62 66.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.069 -1.085 . . . . 0.47 108.069 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 67.24 48.84 1.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.006 0.432 . . . . 1.27 109.924 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 8' ' ' SER . 35.2 mt -127.8 144.69 52.19 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.535 -0.728 . . . . 0.49 109.15 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.87 132.05 8.09 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.712 2.275 . . . . 0.57 113.07 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.31 143.76 4.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.288 -1.507 . . . . 0.57 112.609 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -123.66 146.64 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 107.492 -1.299 . . . . 0.51 107.492 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.84 -5.81 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.421 -0.799 . . . . 0.53 110.417 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.25 21.77 19.21 Favored Glycine 0 N--CA 1.503 3.117 0 O-C-N 121.505 -0.747 . . . . 0.53 111.249 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.7 p -46.06 -42.93 14.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.805 -1.409 . . . . 0.56 110.029 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.48 -53.52 3.1 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.058 -1.068 . . . . 0.59 111.592 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -155.5 32.09 0.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.452 -1.617 . . . . 1.41 111.617 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.42 -39.86 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.49 108.833 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.589 HG22 HG12 ' A' ' 159' ' ' VAL . 53.1 p -54.41 -30.24 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.63 110.496 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 61.4 m -83.46 -15.33 50.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 1.44 110.668 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -101.03 -13.64 18.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.267 -0.896 . . . . 2.2 110.153 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.3 t -106.99 142.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.437 -0.79 . . . . 0.88 109.956 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 213' ' ' LYS . 2.0 mptp? -110.47 165.62 11.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.441 -2.059 . . . . 2.33 105.441 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.7 p-10 -70.39 148.55 48.26 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 119.798 -1.814 . . . . 2.1 109.8 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.2 t0 80.65 6.99 1.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.657 -0.652 . . . . 2.05 110.38 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.95 147.95 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.933 -1.104 . . . . 1.99 108.218 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -94.71 120.47 34.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.984 -1.073 . . . . 0.51 108.681 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -128.41 144.89 51.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.452 -0.78 . . . . 0.54 110.909 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.8 mt -114.63 129.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.041 -1.466 . . . . 0.43 107.041 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.8 tp -104.68 120.3 41.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.93 . . . . 0.53 109.233 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 223' ' ' VAL . 73.0 m-20 -78.58 -38.91 39.02 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.527 -0.916 . . . . 1.89 108.527 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.2 15.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.705 -0.85 . . . . 0.52 108.705 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.0 t -131.83 -43.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.297 -1.372 . . . . 0.61 107.297 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.04 -0.02 39.99 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.398 -1.334 . . . . 2.11 107.398 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 60.43 41.37 16.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.754 -0.591 . . . . 1.3 109.668 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -131.61 148.29 52.59 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.527 -0.733 . . . . 1.44 109.844 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.33 129.82 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.53 108.097 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -100.6 121.23 41.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.75 109.253 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.31 114.87 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.452 -0.78 . . . . 0.59 110.409 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 230' ' ' ASN . 27.2 t-20 54.33 67.36 3.46 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.243 -0.91 . . . . 1.48 110.978 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -92.32 144.09 2.64 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.037 2.491 . . . . 0.76 112.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 22.2 p -71.12 169.16 15.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 1.59 110.325 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.74 -39.73 85.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 2.49 109.827 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -37.37 78.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 2.56 109.908 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.58 -39.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.062 -1.024 . . . . 0.98 108.405 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt -67.42 -47.66 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.39 -0.819 . . . . 0.79 109.373 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 2.44 108.49 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -69.29 -39.72 78.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 2.29 109.005 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.4 mtp -74.63 -29.5 61.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.93 109.369 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -39.95 77.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 2.82 109.531 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.21 92.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.795 . . . . 1.19 109.103 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.37 -43.61 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 1.2 108.779 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.26 -39.78 87.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 2.07 109.369 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -60.16 -39.83 87.75 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.268 -1.012 . . . . 1.95 108.268 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.02 -39.68 86.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.639 -0.875 . . . . 2.48 108.639 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.49 -43.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 1.82 109.046 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.03 87.89 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.811 -0.811 . . . . 2.1 108.811 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -40.18 87.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 2.54 109.075 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.358 -0.839 . . . . 3.29 108.8 179.479 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.087 -0.708 . . . . 1.59 109.087 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -152.36 149.96 29.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.79 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -149.61 158.91 44.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.961 -1.087 . . . . 1.66 110.805 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -152.36 148.7 27.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.022 -0.733 . . . . 1.91 109.022 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 129.83 55.62 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.064 -1.022 . . . . 2.08 109.518 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -130.69 122.44 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-O 122.302 1.048 . . . . 0.43 112.509 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.416 ' O ' HG23 ' B' ' 309' ' ' THR . 48.5 m -77.15 104.48 7.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.755 0.788 . . . . 0.53 110.921 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 41.6 mt -52.66 122.17 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 122.514 1.149 . . . . 0.48 110.894 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.416 HG23 ' O ' ' B' ' 307' ' ' THR . 71.3 p -108.67 19.48 19.65 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.938 -1.028 . . . . 0.59 110.283 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.99 116.58 55.44 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.853 -1.165 . . . . 0.68 107.853 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.37 -14.0 6.14 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 120.707 1.288 . . . . 0.98 113.922 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -120.75 14.86 11.77 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.175 -0.953 . . . . 0.85 109.326 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.94 177.82 45.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.711 -1.756 . . . . 0.52 108.711 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.503 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -81.19 87.02 6.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.91 -1.347 . . . . 0.45 108.701 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 1.221 ' ND1' ' P ' ' B' ' 600' ' ' PO3 . 1.6 p80 -85.73 -168.19 2.14 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.718 -1.239 . . . . 0.36 110.565 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.5 m -56.1 -41.86 75.89 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.238 -0.914 . . . . 0.38 111.277 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 71' ' ' ALA . 10.1 tpt180 -53.28 -62.18 3.91 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.756 -1.215 . . . . 1.73 111.23 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.96 -35.47 87.7 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 CA-C-N 120.217 1.113 . . . . 0.39 110.886 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.6 -53.32 59.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.99 -1.069 . . . . 0.42 108.984 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.44 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.31 109.3 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.421 ' OE1' HD21 ' B' ' 384' ' ' LEU . 28.8 tt0 -71.24 -40.01 71.3 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.802 -1.159 . . . . 2.14 108.616 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -60.7 -51.72 68.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.905 . . . . 0.53 110.731 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 344' ' ' ALA . 57.5 t -65.35 -29.79 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.524 -1.36 . . . . 0.32 109.319 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -61.0 -45.39 94.99 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.45 -0.9 . . . . 1.57 109.515 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.65 -49.9 71.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.146 -0.972 . . . . 1.88 110.096 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.92 63.18 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.971 -1.081 . . . . 0.59 110.965 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -52.88 -14.03 0.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.707 -1.246 . . . . 1.37 109.541 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.2 74.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.346 -1.502 . . . . 0.79 109.346 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -105.98 141.78 36.79 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.969 . . . . 0.81 109.195 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.1 m -90.16 -10.81 43.13 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 1.59 109.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 83.9 p -63.85 153.51 36.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.33 -0.856 . . . . 1.38 110.097 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.71 132.54 46.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 2.6 108.794 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.37 131.55 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.005 -0.739 . . . . 0.53 109.005 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.7 m -129.28 148.43 51.21 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.818 -0.808 . . . . 0.51 108.818 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.95 115.37 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 106.966 -1.494 . . . . 0.59 106.966 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.7 m -103.57 125.5 50.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.823 -1.173 . . . . 0.56 109.827 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.3 t -135.68 120.36 18.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.603 -0.686 . . . . 1.36 109.99 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' B' ' 340' ' ' LYS . 6.8 m-20 41.64 70.8 0.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.645 -0.659 . . . . 2.35 111.102 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 59.89 -8.51 0.05 OUTLIER Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.541 -1.35 . . . . 0.86 112.709 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' B' ' 338' ' ' ASN . 10.5 mttp -109.8 121.74 45.91 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 118.949 1.375 . . . . 2.43 109.599 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.52 147.41 48.41 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.286 -0.884 . . . . 1.29 110.797 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.42 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.07 165.75 26.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.588 -0.695 . . . . 0.43 110.408 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.33 131.32 34.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.48 -0.763 . . . . 1.19 111.065 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.432 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.35 -14.77 62.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.072 -1.018 . . . . 0.35 111.061 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -96.46 21.58 9.01 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.807 -1.553 . . . . 2.52 106.807 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 1.4 t -140.8 91.85 2.45 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.693 -1.139 . . . . 1.34 111.311 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.623 HD11 HE22 ' B' ' 351' ' ' GLN . 51.4 tp -60.24 -36.33 77.49 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.967 -0.753 . . . . 0.38 108.967 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.1 m-85 -56.05 -51.95 66.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.858 -1.151 . . . . 0.33 110.37 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -70.08 -41.24 74.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.709 -1.244 . . . . 1.28 110.73 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.1 mt -48.12 -55.39 10.39 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.774 -1.204 . . . . 0.42 108.291 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.669 ' NE2' HH21 ' A' ' 126' ' ' ARG . 1.2 mp0 -37.68 -21.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.949 -0.47 . . . . 2.08 111.241 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.8 p -86.4 -10.22 54.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.767 -1.208 . . . . 0.43 110.342 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 342' ' ' ALA . 65.3 mt -92.83 116.11 28.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.45 109.395 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.73 92.86 0.81 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.218 -1.553 . . . . 0.48 109.218 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.64 92.0 4.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.282 -1.128 . . . . 0.52 110.305 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.3 p -93.39 179.99 5.23 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.932 -1.105 . . . . 0.6 111.332 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -70.53 112.02 6.48 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.512 -0.742 . . . . 2.05 110.525 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.74 10.86 31.95 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.345 -1.502 . . . . 0.67 109.345 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 79.3 m -90.39 109.64 20.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -1.174 . . . . 0.63 110.845 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.14 116.77 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.215 1.007 . . . . 0.53 108.899 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.54 175.56 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.748 -1.205 . . . . 0.46 107.748 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.6 m -131.73 127.48 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.438 -1.319 . . . . 0.52 107.438 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.39 118.14 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.131 -1.433 . . . . 0.46 107.131 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.04 131.39 55.09 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.622 -0.881 . . . . 1.24 108.622 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -142.48 149.09 38.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -0.92 . . . . 0.62 109.499 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -143.36 121.16 11.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.621 -0.881 . . . . 1.88 108.621 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.38 -159.58 30.98 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.097 -1.525 . . . . 0.84 111.334 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -60.23 -50.31 74.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.154 -0.616 . . . . 2.15 111.645 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 11.4 m-20 -106.3 9.68 31.9 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.755 -1.216 . . . . 1.44 111.967 -177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -41.09 -33.73 0.37 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.895 -1.128 . . . . 2.2 111.862 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.51 -43.75 69.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.077 -1.014 . . . . 2.36 110.948 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -67.95 -48.5 65.71 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.46 -0.896 . . . . 2.18 109.0 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.58 -77.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.326 -0.859 . . . . 0.8 110.03 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.551 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.6 t -44.6 -38.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.298 -0.876 . . . . 0.65 110.822 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -70.11 -39.66 75.35 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.317 -1.49 . . . . 2.19 110.593 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.01 -47.97 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.784 -1.197 . . . . 1.56 109.93 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 39.8 mt -59.96 -35.52 75.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.57 109.522 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.551 HG23 ' O ' ' B' ' 374' ' ' VAL . 28.7 t -64.21 -41.83 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.58 109.175 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -70.4 -57.76 4.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.727 -1.212 . . . . 2.13 107.727 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.85 -29.39 41.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.79 110.358 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.1 ttm -77.45 -35.93 53.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.737 -1.227 . . . . 1.74 108.18 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.34 -9.99 59.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.491 -0.756 . . . . 1.01 110.54 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -110.13 0.0 18.11 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.985 -1.072 . . . . 2.24 111.368 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.421 HD21 ' OE1' ' B' ' 321' ' ' GLN . 14.7 mt -85.13 128.59 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.378 -1.451 . . . . 1.3 109.433 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.735 -1.126 . . . . 2.62 109.285 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 600' ' ' PO3 . . . . . 1.263 ' P ' ' NE2' ' A' ' 189' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_